Allianz Flexes Buyback Muscle as Credit Risk Lurks in the Shadows

Allianz shares trade near 52-week peak, buoyed by a record €2.5 billion buyback and strong Q1 earnings, though overbought conditions and rising insolvencies at Allianz Trade pose risks.

The blue-chip insurer is charting its own course while the broader DAX wavers. Allianz shares have proven remarkably resilient, currently changing hands around €389 — barely 1.4% below a 52-week peak of nearly €395. That strength is underpinned by a shareholder-friendly capital policy that keeps demand for the stock humming even as the index falters.

Buyback Engine Running at Full Throttle

Management is in the midst of a €2.5 billion share repurchase program, the largest such initiative since 2017. First-quarter figures show €300 million already deployed, with all bought-back shares promptly cancelled. Since the end of 2021, the outstanding share count has shrunk from 408.5 million to 380.4 million — a reduction of roughly 7% that automatically lifts earnings per share. Since February 2017, Allianz has executed twelve buyback programmes worth a combined €16 billion, taking 76.6 million shares off the market.

The ambition extends further. For the 2025-2027 period, the group has pledged to return at least 15% of annual net profit attributable to shareholders via buybacks. A record net profit of €17.4 billion in 2025 provides a solid base, and the Solvency-II ratio recently climbed to 221%, leaving ample headroom for both repurchases and dividends. Analysts expect a payout of around €18.37 per share for the current fiscal year.

Two Sets of Q1 Numbers, One Strengthening Picture

First-quarter operating performance offers additional support — though the precise figure depends on which report you read. One disclosure puts operating profit at €2.4 billion, an 11.1% year-on-year improvement and equivalent to 27% of the full-year guidance midpoint of €17.4 billion (plus or minus €1 billion). A separate account highlights a record operating result of €4.5 billion for the same period, representing a near-7% increase. Either way, the underlying earnings momentum is clear.

The balance sheet has also been tidied up. Proceeds from the sale of stakes in Indian joint ventures have been redirected into technology upgrades and more efficient claims processing — moves that should bolster margins over time.

Technical Fever and a Countervailing Risk

All that buying pressure has pushed the stock into technically overheated territory. The 14-day relative strength index stands at 82, a reading that typically warns of exhaustion and a potential pullback. Without fresh catalysts, the assault on the psychologically important €400 mark lacks the necessary fuel.

The most tangible headwind, however, comes from within the group. Allianz Trade, the credit insurance arm, is grappling with rising corporate insolvencies. Global bankruptcies jumped about 6% in 2025, and Germany saw an 11% surge to roughly 24,300 cases. Higher credit losses are weighing on that division directly, and management expects a further, albeit slower, increase in 2026.

The Balancing Act Ahead

CEO Oliver Bäte has reaffirmed the full-year operating profit target of €17.4 billion. August’s second-quarter results will provide the next major check-point. For now, investors are weighing a powerful buyback-driven tailwind against a deteriorating credit cycle in Allianz Trade — a duel that will define the stock’s trajectory in the months ahead.